We are live on ! Find out more
MEDP icon

Medpace

586 hedge funds and large institutions have $7.77B invested in Medpace in 2025 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 232 increasing their positions, 212 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

2.36% more ownership

Funds ownership: 81.42% → 83.78% (+2.4%)

9% more repeat investments, than reductions

Existing positions increased: 232 | Existing positions reduced: 212

0% less capital inflows, than outflows

Capital inflows: $866M | Capital outflows: $868M

1% less funds holding

Funds holding: 592 → 586 (-6)

13% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 72

34% less call options, than puts

Call options by funds: $14.5M | Put options by funds: $22M

Holders
586
Holders Change
-6
Holders Change %
-1.01%
% of All Funds
7.82%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
63
Increased
232
Reduced
212
Closed
72
Calls
$14.5​M
Puts
$22​M
Net Calls
-⁠$7.46​M
Net Calls Change
-⁠$10.2​M

MEDP Hedge Fund Activity: Q1 2025 in Review

586 of the 7,490 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2025, worth a combined $7.77B — down 7.6% from $8.41B a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of MEDP and 63 opened new positions — a net loss of 9 holders — while 212 trimmed existing stakes and 232 added.

The largest buyer was Mawer Investment Management, opening a new position worth an estimated $234M. The largest seller was Capital World Investors, cutting an estimated $146M.

  • 586 institutional investors held Medpace (MEDP) as of Q1 2025, down from 592 in Q4 2024.
  • Funds reported $7.77B of Medpace stock for Q1 2025, down 7.6% quarter-over-quarter.
  • 63 funds opened new Medpace positions in Q1 2025 and 72 closed out, a net change of -9 holders.
  • The largest Medpace buyer in Q1 2025 was Mawer Investment Management, an estimated $234M added.
  • The largest Medpace seller in Q1 2025 was Capital World Investors, an estimated $146M sold.

Based on aggregated 13F filings for Q1 2025.